Review ArticleReview
Pharmacogenetics of Anticancer Drug Sensitivity in Non-Small Cell Lung Cancer
Romano Danesi, Filippo De Braud, Stefano Fogli, Tommaso Martino De Pas, Antonello Di Paolo, Giuseppe Curigliano and Mario Del Tacca
Pharmacological Reviews March 2003, 55 (1) 57-103; DOI: https://doi.org/10.1124/pr.55.1.4
Romano Danesi
1
2
Filippo De Braud
1
2
Stefano Fogli
1
2
Tommaso Martino De Pas
1
2
Antonello Di Paolo
1
2
Giuseppe Curigliano
1
2
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Review ArticleReview
Pharmacogenetics of Anticancer Drug Sensitivity in Non-Small Cell Lung Cancer
Romano Danesi, Filippo De Braud, Stefano Fogli, Tommaso Martino De Pas, Antonello Di Paolo, Giuseppe Curigliano and Mario Del Tacca
Pharmacological Reviews March 1, 2003, 55 (1) 57-103; DOI: https://doi.org/10.1124/pr.55.1.4
Review ArticleReview
Pharmacogenetics of Anticancer Drug Sensitivity in Non-Small Cell Lung Cancer
Romano Danesi, Filippo De Braud, Stefano Fogli, Tommaso Martino De Pas, Antonello Di Paolo, Giuseppe Curigliano and Mario Del Tacca
Pharmacological Reviews March 1, 2003, 55 (1) 57-103; DOI: https://doi.org/10.1124/pr.55.1.4
Jump to section
- Article
- Abstract
- I. Introduction
- II. Clinical Relevance and Management of Non-Small Cell Lung Cancer
- III. Genetic Instability and Gene Dysfunction in Non-Small Cell Lung Cancer
- IV. Genetic Abnormalities in Non-Small Cell Lung Cancer
- V. Potential Role of Pharmacogenetics in Rational Therapeutic Decision
- VI. Influence of Genetic Profile of Non-Small Cell Lung Cancer on Drug Activity
- VII. Integrated Analysis of Drug Activity: Pharmacoproteomics and Pharmacogenomics
- VIII. Concluding Remarks
- Acknowledgments
- Footnotes
- References
- Figures & Data
- Info & Metrics
- eLetters
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement